Gilead Wins Closely Watched Case Involving HIV Drug Side Effects
As Reuters reported, the case addressed whether drugmakers should sacrifice profit on successful products by being required to spend money to develop and quickly commercialize alternative products, sometimes called a "duty to innovate." The California Supreme Court ruled 6-1 in favor of the drugmaker.
https://kffhealthnews.org/morning-breakout/hiv-aids-epidemic-080426/
No hay comentarios:
Publicar un comentario